This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eberhardt, A. W. Articles by Blair, H. C. Search for Related Content PubMed PubMed Citation Articles by Eberhardt, A. W. Articles by Blair, H. C.

Regional Trabecular Bone Matrix Degeneration and Osteocyte Death in Femora of Glucocorticoid- Treated Rabbits¹

Department Biomedical Engineering, University of Alabama at Birmingham (A.W.E., A.Y.-J.), Birmingham, Alabama 35294; Departments of Pathology and Physiology and Cell Biology, University of Pittsburgh and Veterans Affairs Medical Center (H.C.B.), Pittsburgh, Pennsylvania 15261

Address all correspondence and requests for reprints to: Dr. Harry C. Blair, University of Pittsburgh, 705 Scaife Hall, DeSoto & Terrace Streets, Pittsburgh, Pennsylvania 15261. E-mail: hcblair{at}imap.pitt.edu

Glucocorticoids at pharmacological concentrations cause osteoporosis and aseptic necrosis, particularly in the proximal femur. Several mechanisms have been proposed, but the primary events are not clear. We studied changes in the bone structure and cellular activity in femora of glucocorticoid-treated rabbits before the occurrence of fracture or collapse. In rabbits treated 28 days with 4 µmol/kg·day of methylprednisolone acetate, changes in the cortical bone were minor. However, metabolic labeling showed that bone formation was virtually absent in the subarticular trabecular bone, and scanning electron microscopy showed resorption of 50–80% of the trabecular surface. Thus, reduction in bone synthesis and increased resorption were involved in bone loss. Vascular changes, which have been hypothesized to mediate glucocorticoid damage, were not seen, but histological changes suggested that trabecular bone was damaged. Matrix integrity was examined using laser scanning confocal microscopy to detect passive tetracycline adsorption. In treated animals, but not controls, tetracycline was adsorbed, in a novel lamellar pattern, in 50–200 µm regions extending deep into trabeculae. This showed that the matrix, which is normally impervious, was exposed at these sites. TUNEL assays showed that matrix damage correlated with cell death in the subarticular trabecular bone of treated animals. The pattern of cell death involving cohorts of osteoblasts and osteocytes comprised up to half of the bone volume in affected regions and is consistent with an apoptotic mechanism. Small numbers of TUNEL-labeled osteoblasts, but no osteocytes, were detected in control bone. We conclude that exposure of bone matrix permeability and that regional cell death consistent with apoptosis is an early event in glucocorticoid-induced bone damage.

This article has been cited by other articles:

				F.-S. Wang, J.-Y. Ko, D.-W. Yeh, H.-C. Ke, and H.-L. Wu Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss Endocrinology, April 1, 2008; 149(4): 1793 - 1801. [Abstract] [Full Text] [PDF]

				P. Chavassieux, E. Seeman, and P. D. Delmas Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease Endocr. Rev., April 1, 2007; 28(2): 151 - 164. [Abstract] [Full Text] [PDF]

				V. Tasic, Z. Trajkovski, G. Zafirovski, Z. Gucev, and R. S. Trompeter Aseptic necrosis of both tali in a child with steroid-dependent nephrotic syndrome Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1702 - 1704. [Full Text] [PDF]

				C. Kristo, R. Jemtland, T. Ueland, K. Godang, and J. Bollerslev Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study Eur. J. Endocrinol., January 1, 2006; 154(1): 109 - 118. [Abstract] [Full Text] [PDF]

				L. Sun, H. C. Blair, Y. Peng, N. Zaidi, O. A. Adebanjo, X. B. Wu, X. Y. Wu, J. Iqbal, S. Epstein, E. Abe, et al. Calcineurin regulates bone formation by the osteoblast PNAS, November 22, 2005; 102(47): 17130 - 17135. [Abstract] [Full Text] [PDF]

				G. Talamo, E. Angtuaco, R. C. Walker, L. Dong, M. H. Miceli, M. Zangari, G. Tricot, B. Barlogie, and E. Anaissie Avascular Necrosis of Femoral and/or Humeral Heads in Multiple Myeloma: Results of a Prospective Study of Patients Treated With Dexamethasone-Based Regimens and High-Dose Chemotherapy J. Clin. Oncol., August 1, 2005; 23(22): 5217 - 5223. [Abstract] [Full Text] [PDF]

				F.-S. Wang, C.-L. Lin, Y.-J. Chen, C.-J. Wang, K. D. Yang, Y.-T. Huang, Y.-C. Sun, and H.-C. Huang Secreted Frizzled-Related Protein 1 Modulates Glucocorticoid Attenuation of Osteogenic Activities and Bone Mass Endocrinology, May 1, 2005; 146(5): 2415 - 2423. [Abstract] [Full Text] [PDF]

				R Okazaki, A Sakai, A Ootsuyama, T Sakata, T Nakamura, and T Norimura Trabecular bone mass and bone formation are preserved after limb immobilisation in p53 null mice Ann Rheum Dis, April 1, 2004; 63(4): 453 - 456. [Abstract] [Full Text] [PDF]

				A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-{beta} by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts J. Biol. Chem., November 7, 2003; 278(45): 44667 - 44674. [Abstract] [Full Text] [PDF]

				J. H. Boss and I. Misselevich Osteonecrosis of the Femoral Head of Laboratory Animals: The Lessons Learned from a Comparative Study of Osteonecrosis in Man and Experimental Animals Vet. Pathol., July 1, 2003; 40(4): 345 - 354. [Abstract] [Full Text] [PDF]